Murray W. Huff - Publications

Affiliations: 
The University of Western Ontario (Canada) 
Area:
Biochemistry, Nutrition

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Burke AC, Sutherland BG, Telford DE, Morrow MR, Sawyez CG, Edwards JY, Huff MW. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr mice. Atherosclerosis. 286: 60-70. PMID 31102954 DOI: 10.1016/J.Atherosclerosis.2019.05.009  0.76
2018 Burke AC, Telford DE, Edwards JY, Sutherland BG, Sawyez CG, Huff MW. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr Mice. Molecular Nutrition & Food Research. e1800833. PMID 30578663 DOI: 10.1002/Mnfr.201800833  0.76
2018 Burke AC, Sutherland BG, Telford DE, Morrow MR, Sawyez CG, Edwards JY, Drangova M, Huff MW. Intervention with citrus flavonoids reverses obesity, and improves metabolic syndrome and atherosclerosis in obese Ldlr-/- mice. Journal of Lipid Research. PMID 30008441 DOI: 10.1194/Jlr.M087387  0.76
2018 Burke AC, Telford DE, Sutherland BG, Edwards JY, Sawyez CG, Barrett PHR, Newton RS, Pickering JG, Huff MW. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (and) Yucatan Miniature Pigs. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 29449335 DOI: 10.1161/Atvbaha.117.310676  0.76
2017 Samsoondar JP, Burke AC, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Pinkosky SL, Newton RS, Huff MW. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr-/- Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 28153881 DOI: 10.1161/Atvbaha.116.308963  0.76
2016 Wang J, Dron JS, Ban MR, Robinson JF, McIntyre AD, Alazzam M, Zhao PJ, Dilliott AA, Cao H, Huff MW, Rhainds D, Low-Kam C, Dubé MP, Lettre G, Tardif JC, et al. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27765764 DOI: 10.1161/Atvbaha.116.308027  0.4
2016 Burke AC, Dron JS, Hegele RA, Huff MW. PCSK9: Regulation and Target for Drug Development for Dyslipidemia. Annual Review of Pharmacology and Toxicology. PMID 27575716 DOI: 10.1146/Annurev-Pharmtox-010716-104944  0.4
2015 Assini JM, Mulvihill EE, Burke AC, Sutherland BG, Telford DE, Chhoker SS, Sawyez CG, Drangova M, Adams AC, Kharitonenkov A, Pin CL, Huff MW. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21. Endocrinology. 156: 2087-102. PMID 25774553 DOI: 10.1210/En.2014-2003  0.36
2015 Huff MW, Pickering JG. Can a vascular smooth muscle-derived foam-cell really change its spots? Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 492-5. PMID 25717175 DOI: 10.1161/Atvbaha.115.305225  0.32
2015 Hussain Y, Ding Q, Connelly PW, Brunt JH, Ban MR, McIntyre AD, Huff MW, Gros R, Hegele RA, Feldman RD. G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 213-21. PMID 25395619 DOI: 10.1161/Atvbaha.114.304326  0.36
2014 Huff MW, Assini JM, Hegele RA. Gene therapy for hypercholesterolemia: sweet dreams and flying machines. Circulation Research. 115: 542-5. PMID 25170090 DOI: 10.1161/Circresaha.114.304800  0.4
2014 Bojic LA, Telford DE, Fullerton MD, Ford RJ, Sutherland BG, Edwards JY, Sawyez CG, Gros R, Kemp BE, Steinberg GR, Huff MW. PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity. Journal of Lipid Research. 55: 1254-1266. PMID 24864274 DOI: 10.1194/Jlr.M046037  0.36
2014 Bojic LA, Burke AC, Chhoker SS, Telford DE, Sutherland BG, Edwards JY, Sawyez CG, Tirona RG, Yin H, Pickering JG, Huff MW. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 52-60. PMID 24158519 DOI: 10.1161/Atvbaha.113.301830  0.76
2013 Huff MW, Hegele RA. Apolipoprotein C-III: going back to the future for a lipid drug target. Circulation Research. 112: 1405-8. PMID 23704213 DOI: 10.1161/Circresaha.113.301464  0.4
2013 Assini JM, Mulvihill EE, Sutherland BG, Telford DE, Sawyez CG, Felder SL, Chhoker S, Edwards JY, Gros R, Huff MW. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice. Journal of Lipid Research. 54: 711-24. PMID 23269394 DOI: 10.1194/jlr.M032631  0.36
2012 Beyea MM, Reaume S, Sawyez CG, Edwards JY, O'Neil C, Hegele RA, Pickering JG, Huff MW. The oxysterol 24(s),25-epoxycholesterol attenuates human smooth muscle-derived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux. Journal of the American Heart Association. 1: e000810. PMID 23130136 DOI: 10.1161/Jaha.112.000810  0.76
2012 Bojic LA, Sawyez CG, Telford DE, Edwards JY, Hegele RA, Huff MW. Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 2919-28. PMID 23023367 DOI: 10.1161/Atvbaha.112.255208  0.76
2012 Johansen CT, Wang J, McIntyre AD, Martins RA, Ban MR, Lanktree MB, Huff MW, Péterfy M, Mehrabian M, Lusis AJ, Kathiresan S, Anand SS, Yusuf S, Lee AH, Glimcher LH, et al. Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia. Circulation. Cardiovascular Genetics. 5: 66-72. PMID 22135386 DOI: 10.1161/Circgenetics.111.960864  0.4
2011 Johansen CT, Wang J, Lanktree MB, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, Schwartz SM, Voight BF, Elosua R, Salomaa V, O'Donnell CJ, Dallinga-Thie GM, ... ... Huff MW, et al. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 1916-26. PMID 21597005 DOI: 10.1161/Atvbaha.111.226365  0.36
2011 Mulvihill EE, Assini JM, Lee JK, Allister EM, Sutherland BG, Koppes JB, Sawyez CG, Edwards JY, Telford DE, Charbonneau A, St-Pierre P, Marette A, Huff MW. Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. Diabetes. 60: 1446-57. PMID 21471511 DOI: 10.2337/Db10-0589  0.36
2010 Marcel Y, McBride H, Milne RW, Huff M, Daugherty A. In memoriam: Stewart Charles Whitman (1964-2010). Journal of Lipid Research. 51: 3089-90. PMID 20699422 DOI: 10.1194/Jlr.E009894  0.36
2010 Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, Schwartz SM, Voight BF, Elosua R, Salomaa V, O'Donnell CJ, ... ... Huff MW, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nature Genetics. 42: 684-7. PMID 20657596 DOI: 10.1038/Ng.628  0.36
2010 Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 742-8. PMID 20110573 DOI: 10.1161/Atvbaha.109.201095  0.4
2010 Lahiry P, Cao H, Ban MR, Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Huff MW, Connelly PW, Hegele RA. APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians. Journal of Lipid Research. 51: 843-8. PMID 19812053 DOI: 10.1194/Jlr.P002014  0.4
2009 Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, Anand S, Yusuf S, Huff MW, Wang J. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Human Molecular Genetics. 18: 4189-94. PMID 19656773 DOI: 10.1093/Hmg/Ddp361  0.4
2009 Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 58: 2198-210. PMID 19592617 DOI: 10.2337/Db09-0634  0.76
2009 Frontini MJ, O'Neil C, Sawyez C, Chan BM, Huff MW, Pickering JG. Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells. Circulation Research. 104: 832-41. PMID 19229059 DOI: 10.1161/Circresaha.108.187302  0.32
2008 Wang J, Ban MR, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia. Nature Clinical Practice. Cardiovascular Medicine. 5: 730-7. PMID 18779834 DOI: 10.1038/Ncpcardio1326  0.4
2008 Klein JH, Hegele RA, Hackam DG, Koschinsky ML, Huff MW, Spence JD. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1851-6. PMID 18599799 DOI: 10.1161/Atvbaha.108.169292  0.4
2008 Wang J, Ban MR, Zou GY, Cao H, Lin T, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA. Polygenic determinants of severe hypertriglyceridemia. Human Molecular Genetics. 17: 2894-9. PMID 18596051 DOI: 10.1093/Hmg/Ddn188  0.4
2008 Allister EM, Mulvihill EE, Barrett PH, Edwards JY, Carter LP, Huff MW. Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor. Journal of Lipid Research. 49: 2218-29. PMID 18587069 DOI: 10.1194/Jlr.M800297-Jlr200  0.36
2008 Al-Attar SA, Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovascular Diabetology. 7: 5. PMID 18339204 DOI: 10.1186/1475-2840-7-5  0.4
2007 Lahiry P, Ban MR, Pollex RL, Feldman RD, Sawyez CG, Huff MW, Young TK, Bjerregaard P, Hegele RA. Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders. International Journal of Circumpolar Health. 66: 390-400. PMID 18274205  0.4
2007 Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA. Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample. Bmc Medical Genetics. 8: 80. PMID 18096054 DOI: 10.1186/1471-2350-8-80  0.4
2007 Beyea MM, Heslop CL, Sawyez CG, Edwards JY, Markle JG, Hegele RA, Huff MW. Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol. The Journal of Biological Chemistry. 282: 5207-16. PMID 17186944 DOI: 10.1074/Jbc.M611063200  0.36
2007 Telford DE, Sutherland BG, Edwards JY, Andrews JD, Barrett PH, Huff MW. The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. Journal of Lipid Research. 48: 699-708. PMID 17130282 DOI: 10.1194/Jlr.M600439-Jlr200  0.84
2006 Wang J, Robinson JF, O'Neil CH, Edwards JY, Williams CM, Huff MW, Pickering JG, Hegele RA. Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles. Journal of Human Genetics. 51: 934-42. PMID 17033732 DOI: 10.1007/S10038-006-0042-0  0.76
2006 Huff MW, Pollex RL, Hegele RA. NPC1L1: evolution from pharmacological target to physiological sterol transporter. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 2433-8. PMID 16973966 DOI: 10.1161/01.ATV.0000245791.53245.ee  0.4
2005 Burnett JR, Telford DE, Barrett PH, Huff MW. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Biochimica Et Biophysica Acta. 1738: 10-8. PMID 16427354 DOI: 10.1016/J.Bbalip.2005.11.010  0.84
2005 Telford DE, Lipson SM, Barrett PH, Sutherland BG, Edwards JY, Aebi JD, Dehmlow H, Morand OH, Huff MW. A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 2608-14. PMID 16210564 DOI: 10.1161/01.Atv.0000189158.28455.94  0.84
2005 Carter DE, Robinson JF, Allister EM, Huff MW, Hegele RA. Quality assessment of microarray experiments. Clinical Biochemistry. 38: 639-42. PMID 15923000 DOI: 10.1016/j.clinbiochem.2005.04.010  0.36
2005 Allister EM, Borradaile NM, Edwards JY, Huff MW. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes. 54: 1676-83. PMID 15919788 DOI: 10.2337/Diabetes.54.6.1676  1
2005 Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. The Journal of Biological Chemistry. 280: 22212-21. PMID 15817453 DOI: 10.1074/Jbc.M502761200  0.76
2004 Argmann CA, Sawyez CG, Li S, Nong Z, Hegele RA, Pickering JG, Huff MW. Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 1290-6. PMID 15130914 DOI: 10.1161/01.Atv.0000131260.80316.37  0.4
2003 Borradaile NM, de Dreu LE, Huff MW. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes. 52: 2554-61. PMID 14514640 DOI: 10.2337/Diabetes.52.10.2554  1
2003 Rowe AH, Argmann CA, Edwards JY, Sawyez CG, Morand OH, Hegele RA, Huff MW. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circulation Research. 93: 717-25. PMID 14512442 DOI: 10.1161/01.Res.0000097606.43659.F4  0.76
2003 Argmann CA, Sawyez CG, McNeil CJ, Hegele RA, Huff MW. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 475-82. PMID 12615696 DOI: 10.1161/01.Atv.0000058860.62870.6E  0.4
2003 Borradaile NM, de Dreu LE, Barrett PH, Behrsin CD, Huff MW. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation. Biochemistry. 42: 1283-91. PMID 12564931 DOI: 10.1021/Bi026731O  1
2003 Telford DE, Edwards JY, Lipson SM, Sutherland B, Barrett PH, Burnett JR, Krul ES, Keller BT, Huff MW. Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB. Journal of Lipid Research. 44: 943-52. PMID 12562847 DOI: 10.1194/Jlr.M200482-Jlr200  0.84
2003 Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, Cao H. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 111-6. PMID 12524233  0.4
2002 Huff MW, Telford DE, Edwards JY, Burnett JR, Barrett PH, Rapp SR, Napawan N, Keller BT. Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1884-91. PMID 12426220 DOI: 10.1161/01.Atv.0000035390.87288.26  0.84
2002 Borradaile NM, de Dreu LE, Barrett PH, Huff MW. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. Journal of Lipid Research. 43: 1544-54. PMID 12235187 DOI: 10.1194/Jlr.M200115-Jlr200  1
2002 Borradaile NM, de Dreu LE, Wilcox LJ, Edwards JY, Huff MW. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. The Biochemical Journal. 366: 531-9. PMID 12030847 DOI: 10.1042/Bj20020046  1
2002 Al-Shali K, Wang J, Fellows F, Huff MW, Wolfe BM, Hegele RA. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. Clinical Biochemistry. 35: 125-30. PMID 11983347 DOI: 10.1016/S0009-9120(02)00283-7  0.4
2001 Argmann CA, Van Den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BM, Huff MW. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 2011-8. PMID 11742878 DOI: 10.1161/Hq1201.099426  0.76
2001 Hegele RA, Huff MW, Young TK. Common genomic variation in LMNA modulates indexes of obesity in Inuit Journal of Clinical Endocrinology and Metabolism. 86: 2747-2751. PMID 11397881 DOI: 10.1210/JCEM.86.6.7550  0.36
2001 Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. Journal of Lipid Research. 42: 725-34. PMID 11352979  1
2000 Wolfe BM, Barrett PH, Laurier L, Huff MW. Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women. Journal of Lipid Research. 41: 368-75. PMID 10706584  0.84
1999 Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW. The Magnitude of Decrease in Hepatic Very Low Density Lipoprotein Apolipoprotein B Secretion Is Determined by the Extent of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition in Miniature Pigs1. Endocrinology. 140: 5293-5302. PMID 28200735 DOI: 10.1210/endo.140.11.7150  0.84
1999 Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Endocrinology. 140: 5293-302. PMID 10537160 DOI: 10.1210/Endo.140.11.7150  0.84
1999 Burnett JR, Wilcox LJ, Huff MW. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion. Clinica Chimica Acta; International Journal of Clinical Chemistry. 286: 231-42. PMID 10511295 DOI: 10.1016/S0009-8981(99)00104-7  0.76
1999 Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Journal of Lipid Research. 40: 1317-27. PMID 10393217  0.84
1999 Wilcox LJ, Barrett PH, Huff MW. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. Journal of Lipid Research. 40: 1078-89. PMID 10357840  0.84
1999 Whitman SC, Argmann CA, Sawyez CG, Miller DB, Hegele RA, Huff MW. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. Journal of Lipid Research. 40: 1017-28. PMID 10357833  0.4
1999 Whitman SC, Hazen SL, Miller DB, Hegele RA, Heinecke JW, Huff MW. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 1238-49. PMID 10323775 DOI: 10.1161/01.Atv.19.5.1238  0.4
1999 Wilcox LJ, Barrett PH, Newton RS, Huff MW. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 939-49. PMID 10195921 DOI: 10.1161/01.Atv.19.4.939  0.84
1998 Burnett JR, Barrett PH, Vicini P, Miller DB, Telford DE, Kleinstiver SJ, Huff MW. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1906-14. PMID 9848883 DOI: 10.1161/01.Atv.18.12.1906  0.84
1998 Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Huff MW. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol. Biochimica Et Biophysica Acta. 1393: 63-79. PMID 9714740 DOI: 10.1016/S0005-2760(98)00059-9  0.84
1998 Whitman SC, Sawyez CG, Miller DB, Wolfe BM, Huff MW. Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL. Journal of Lipid Research. 39: 1008-20. PMID 9610767  0.4
1997 Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 2589-600. PMID 9409231 DOI: 10.1161/01.Atv.17.11.2589  0.84
1997 Kang AK, Jenkins DJA, Wolever TMS, Huff MW, Maguire GF, Connelly PW, Hegele RA. Apolipoprotein E R112; R251G: A carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease Mutation Research - Mutation Research Genomics. 382: 57-65. PMID 9360638 DOI: 10.1016/S1383-5726(97)00009-5  0.36
1997 Whitman SC, Miller DB, Wolfe BM, Hegele RA, Huff MW. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 1707-15. PMID 9327767 DOI: 10.1161/01.Atv.17.9.1707  0.4
1997 Huff MW, Miller DB, Wolfe BM, Connelly PW, Sawyez CG. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: The role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans Journal of Lipid Research. 38: 1318-1333. PMID 9254059  0.36
1996 Ingram AJ, Parbtani A, Clark WF, Spanner E, Huff MW, Philbrick DJ, Holub BJ, Scholey JW. Dietary alteration of dihomogamma-linolenic acid/arachidonic acid ratio in a rat 5/6-renal-ablation model Journal of the American Society of Nephrology. 7: 1024-1031. PMID 8829117  0.36
1995 Wolfe BM, Huff MW. Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women. Metabolism: Clinical and Experimental. 44: 410-7. PMID 7885290 DOI: 10.1016/0026-0495(95)90175-2  0.36
1995 Miller DB, Hegele RA, Wolfe BM, Huff MW. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia. The Journal of Clinical Endocrinology and Metabolism. 80: 807-13. PMID 7883834 DOI: 10.1210/Jcem.80.3.7883834  0.4
1995 Ingram AJ, Parbtani A, Clark WF, Spanner E, Huff MW, Philbrick DJ, Holub BJ. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model American Journal of Kidney Diseases. 25: 320-329. PMID 7847360 DOI: 10.1016/0272-6386(95)90015-2  0.36
1994 Huff MW, Telford DE, Barrett PH, Billheimer JT, Gillies PJ. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet. Arteriosclerosis and Thrombosis : a Journal of Vascular Biology. 14: 1498-508. PMID 8068612 DOI: 10.1161/01.Atv.14.9.1498  0.84
1994 Walden CC, Huff MW, Leiter LA, Connelly PW, Hegele RA. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping. The Journal of Clinical Endocrinology and Metabolism. 78: 699-704. PMID 7907341 DOI: 10.1210/jcem.78.3.7907341  0.36
1993 Evans AJ, Sawyez CG, Wolfe BM, Connelly PW, Maguire GF, Huff MW. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms Journal of Lipid Research. 34: 703-717. PMID 8509711  0.36
1993 Evans AJ, Wolfe BM, Strong WL, Huff MW. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo. Metabolism: Clinical and Experimental. 42: 105-15. PMID 8446037 DOI: 10.1016/0026-0495(93)90180-V  0.36
1993 Huff MW, Sawyez CG, Connelly PW, Maguire GF, Alick Little J, Hegele RA. β-VLDL in hepatic lipase deficiency induces ApoE-mediated cholesterol ester accumulation in macrophages Arteriosclerosis, Thrombosis, and Vascular Biology. 13: 1282-1290. PMID 8364012 DOI: 10.1161/01.Atv.13.9.1282  0.36
1993 Wolfe BM, Huff MW. Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women. The Journal of Clinical Investigation. 92: 456-61. PMID 8326011 DOI: 10.1172/JCI116588  0.36
1993 Huff MW, Telford DE, Edmonds BW, McDonald CG, Evans AJ. Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil. Biochimica Et Biophysica Acta. 1210: 113-22. PMID 8257713 DOI: 10.1016/0005-2760(93)90056-F  0.36
1992 Huff MW, Telford DE, Barrett PH. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs. Arteriosclerosis and Thrombosis : a Journal of Vascular Biology. 12: 902-10. PMID 1637788 DOI: 10.1161/01.Atv.12.8.902  0.84
1992 Evans AJ, Sawyez CG, Wolfe BM, Huff MW. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. The Journal of Biological Chemistry. 267: 10743-51. PMID 1587849  0.4
1991 Huff MW, Evans AJ, Sawyez CG, Wolfe BM, Nestel PJ. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias. Arteriosclerosis and Thrombosis : a Journal of Vascular Biology. 11: 221-33. PMID 1998641 DOI: 10.1161/01.Atv.11.2.221  0.4
1991 Hegele RA, Connelly PW, Maguire GF, Huff MW, Leiter L, Wolfe BM, Evans AJ, Little JA. An apolipoprotein CII mutation, CIILys19----Thr' identified in patients with hyperlipidemia. Disease Markers. 9: 73-80. PMID 1782747  0.36
1990 Huff MW, Evans AJ, Wolfe BM, Connelly PW, Maguire GF, Strong WLP. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject Journal of Lipid Research. 31: 385-396. PMID 2341805  0.36
1989 Khosla P, Samman S, Carroll KK, Huff MW. Turnover of 125I-VLDL and 131I-LDL apolipoprotein B in rabbits fed diets containing casein or soy protein. Biochimica Et Biophysica Acta. 1002: 157-63. PMID 2930765 DOI: 10.1016/0005-2760(89)90282-8  1
1989 Wolfe BM, Huff MW. Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women. The Journal of Clinical Investigation. 83: 40-5. PMID 2910918 DOI: 10.1172/JCI113882  0.36
1989 Evans AJ, Huff MW, Wolfe BM. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men. Journal of Lipid Research. 30: 1691-701. PMID 2614271  0.36
1988 Huff MW, Breckenridge WC, Strong WL, Wolfe BM. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis. Arteriosclerosis (Dallas, Tex.). 8: 471-9. PMID 3190554 DOI: 10.1161/01.Atv.8.5.471  0.36
1986 Khokha R, Huff MW, Wolfe BM. Divergent effects of d-norgestrel on the metabolism of rat very low density and low density apolipoprotein B. Journal of Lipid Research. 27: 699-705. PMID 3760708  0.36
1984 Huff MW, Giovannetti PM, Wolfe BM. Turnover of very low-density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men American Journal of Clinical Nutrition. 39: 888-897. PMID 6539062  0.36
1982 Huff MW, Roberts DC, Carroll KK. Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits. Atherosclerosis. 41: 327-36. PMID 7199927 DOI: 10.1016/0021-9150(82)90197-6  1
1980 Huff MW, Carroll KK. Effects of dietary protein on turnover, oxidation, and absorption of cholesterol, and on steroid excretion in rabbits. Journal of Lipid Research. 21: 546-48. PMID 7400686  1
1980 Huff MW, Carroll KK. Effects of dietary proteins and amino acid mixtures on plasma cholesterol levels in rabbits. The Journal of Nutrition. 110: 1676-85. PMID 7190603 DOI: 10.1093/Jn/110.8.1676  1
1979 Roberts DC, Huff MW, Carroll KK. Influence of diet on plasma cholesterol concentrations in suckling and weanling rabbits. Nutrition and Metabolism. 23: 476-86. PMID 547207 DOI: 10.1159/000176294  1
1979 Roberts DC, Huff MW, Carroll KK. Plasma lipoprotein changes in suckling and weanling rabbits fed semipurified diets. Lipids. 14: 566-71. PMID 222992 DOI: 10.1007/Bf02533533  1
1979 Karlsson I, Marthens Ev, Zamenhof S, Firestone C, Eklund A, Rask L, Loriette C, Pasantes-Morales H, Portemer C, Chatagner F, Roberts DCK, Huff MW, Carroll KK, Whitear SH, Basu TK, et al. Subject Index, Vol. 23, 1979 Annals of Nutrition and Metabolism. 23: 494-496. DOI: 10.1159/000176297  1
1979 Karlsson I, Marthens Ev, Zamenhof S, Firestone C, Eklund A, Rask L, Loriette C, Pasantes-Morales H, Portemer C, Chatagner F, Roberts DCK, Huff MW, Carroll KK, Whitear SH, Basu TK, et al. Contents, Vol. 23, 1979 Annals of Nutrition and Metabolism. 23. DOI: 10.1159/000176288  1
1978 Carroll KK, Hamilton RM, Huff MW, Falconer AD. Dietary fiber and cholesterol metabolism in rabbits and rats. The American Journal of Clinical Nutrition. 31: S203-S207. PMID 707374 DOI: 10.1093/Ajcn/31.10.S203  1
1978 Carroll KK, Giovannetti PM, Huff MW, Moase O, Roberts DC, Wolfe BM. Hypocholesterolemic effect of substituting soybean protein for animal protein in the diet of healthy young women. The American Journal of Clinical Nutrition. 31: 1312-21. PMID 567007 DOI: 10.1093/Ajcn/31.8.1312  0.36
1977 Carroll KK, Huff MW. Influence of dietary fat and protein on plasma cholesterol levels in the early postnatal period. Advances in Experimental Medicine and Biology. 82: 638-43. PMID 920420 DOI: 10.1007/978-1-4613-4220-5_134  1
1977 Huff MW, Hamilton RM, Carroll KK. Effects of dietary proteins and amino acids on the plasma cholesterol concentrations of rabbits fed cholesterol-free diets. Advances in Experimental Medicine and Biology. 82: 275-7. PMID 920374 DOI: 10.1007/978-1-4613-4220-5_62  1
1977 Huff MW, Hamilton RM, Carroll KK. Plasma cholesterol levels in rabbits fed low fat, cholesterol-free, semipurified diets: effects of dietary proteins, protein hydrolysates and amino acid mixtures. Atherosclerosis. 28: 187-95. PMID 562170 DOI: 10.1016/0021-9150(77)90156-3  1
Show low-probability matches.